These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 3355087

  • 1. Development of a direct fluoroimmunoassay for serum levels of 17-hydroxyprogesterone.
    el-Gamal BA, Eremin SA, Smith DS, Landon J.
    Ann Clin Biochem; 1988 Jan; 25 ( Pt 1)():35-41. PubMed ID: 3355087
    [Abstract] [Full Text] [Related]

  • 2. Development of a direct [125I]radioimmunoassay for serum levels of 17-hydroxyprogesterone.
    el-Gamal BA, Perry LA, Landon J.
    Scand J Clin Lab Invest; 1988 Oct; 48(6):513-8. PubMed ID: 3217754
    [Abstract] [Full Text] [Related]

  • 3. Comparison of separation techniques in radioimmunoassays for 17-hydroxyprogesterone.
    el-Gamal BA, Landon J.
    Clin Chim Acta; 1988 Apr 15; 173(2):201-16. PubMed ID: 3378359
    [Abstract] [Full Text] [Related]

  • 4. 125I radioimmunoassay for 17 alpha-hydroxyprogesterone in plasma, for diagnosing and managing congenital adrenal hyperplasia.
    Yeo KH, Whitau WJ.
    Clin Chem; 1985 Mar 15; 31(3):454-6. PubMed ID: 3971567
    [Abstract] [Full Text] [Related]

  • 5. Screening for congenital adrenal hyperplasia: the Delfia Screening Test overestimates serum 17-hydroxyprogesterone in preterm infants.
    al Saedi S, Dean H, Dent W, Stockl E, Cronin C.
    Pediatrics; 1996 Jan 15; 97(1):100-2. PubMed ID: 8545200
    [Abstract] [Full Text] [Related]

  • 6. Comparison of basal and adrenocorticotropin-stimulated plasma 21-deoxycortisol and 17-hydroxyprogesterone values as biological markers of late-onset adrenal hyperplasia.
    Fiet J, Gueux B, Gourmelen M, Kuttenn F, Vexiau P, Couillin P, Pham-Huu-Trung MT, Villette JM, Raux-Demay MC, Galons H.
    J Clin Endocrinol Metab; 1988 Apr 15; 66(4):659-67. PubMed ID: 2831244
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Blood-spot 17-hydroxyprogesterone daily profiles in infants with congenital adrenal hyperplasia.
    Sólyom J, Hosszu E, Gács G.
    Exp Clin Endocrinol; 1990 Sep 15; 96(1):52-6. PubMed ID: 2279525
    [Abstract] [Full Text] [Related]

  • 9. [Neonatal levels of 17-hydroxyprogesterone--early diagnosis of adrenogenital syndrome].
    Sulcová J, Tichá H, Wiererová O.
    Cesk Pediatr; 1989 Dec 15; 44(12):716-8. PubMed ID: 2636556
    [Abstract] [Full Text] [Related]

  • 10. A chemiluminescent method for the measurement of pregnanetriol-3 alpha-glucuronide in human diluted urine.
    Pinzani P, Magini A, Franceschetti F, Messeri G, Pazzagli M.
    J Biolumin Chemilumin; 1989 Jul 15; 4(1):580-6. PubMed ID: 2552757
    [Abstract] [Full Text] [Related]

  • 11. A bloodspot androstenedione assay suitable for home-monitoring of steroid replacement therapy in congenital adrenal hyperplasia.
    Egan SM, Betts P, Thomson S, Wallace AM, Wood PJ.
    Ann Clin Biochem; 1989 May 15; 26 ( Pt 3)():262-7. PubMed ID: 2669617
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Diurnal variation in blood 17-hydroxyprogesterone concentrations in untreated congenital adrenal hyperplasia.
    Sólyom J.
    Arch Dis Child; 1984 Aug 15; 59(8):743-7. PubMed ID: 6541026
    [Abstract] [Full Text] [Related]

  • 14. [Use of steroid indicators in monitoring the treatment of congenital adrenal hyperplasia].
    Sulcová J, Lisá L, Dvorák P, Hampl R, Stárka L.
    Cesk Pediatr; 1990 Jun 15; 45(6):353-6. PubMed ID: 2289256
    [Abstract] [Full Text] [Related]

  • 15. 17-Hydroxyprogesterone rhythms and growth velocity in congenital adrenal hyperplasia.
    Pincus DR, Kelnar CJ, Wallace AM.
    J Paediatr Child Health; 1993 Aug 15; 29(4):302-4. PubMed ID: 8373678
    [Abstract] [Full Text] [Related]

  • 16. Salivary and plasma androstenedione and 17-hydroxyprogesterone levels in congenital adrenal hyperplasia.
    Otten BJ, Wellen JJ, Rijken JC, Stoelinga GB, Benraad TJ.
    J Clin Endocrinol Metab; 1983 Dec 15; 57(6):1150-4. PubMed ID: 6605355
    [Abstract] [Full Text] [Related]

  • 17. [Salivary 17-hydroxyprogesterone concentration in monitoring of the treatment of congenital adrenal hyperplasia].
    Arisaka O, Shimura N, Nakayama Y, Arisaka M, Yabuta K.
    Dtsch Med Wochenschr; 1988 Dec 09; 113(49):1913-5. PubMed ID: 3197614
    [Abstract] [Full Text] [Related]

  • 18. A rapid assay for 17 alpha OH-progesterone in plasma, saliva and amniotic fluid using a magnetisable solid-phase antiserum.
    Dyas J, Read GF, Guha-Maulik T, Hughes IA, Riad-Fahmy D.
    Ann Clin Biochem; 1984 Sep 09; 21 ( Pt 5)():417-24. PubMed ID: 6508213
    [Abstract] [Full Text] [Related]

  • 19. [Value of the assay of plasma steroids in the control of congenital adrenal hyperplasia].
    Theintz GE, Sizonenko PC.
    Arch Fr Pediatr; 1985 Mar 09; 42(3):211-7. PubMed ID: 4004483
    [Abstract] [Full Text] [Related]

  • 20. Enzyme-linked immunosorbent assay for 17 alpha-hydroxyprogesterone in dried blood spotted on filter paper.
    Maeda M, Arakawa H, Tsuji A, Yamagami Y, Isozaki A, Takahashi T, Haruki E.
    Clin Chem; 1987 Jun 09; 33(6):761-4. PubMed ID: 3594810
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.